Evaxion is a startup based in Denmark, most recent round Pre-ipo.
Evaxion is a company headquartered in Denmark. Its most recent tracked round is Pre-ipo.
Evaxion develops novel vaccine candidates for cancer and infectious diseases by using a proprietary AI platform, AI-Immunology™, to decode the human immune system and accelerate drug discovery and development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.